中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2015年
17期
2574-2576,2577
,共4页
陈琪枫%方晓明%胡新根%姜朝晖%张宝燕%姚宁
陳琪楓%方曉明%鬍新根%薑朝暉%張寶燕%姚寧
진기풍%방효명%호신근%강조휘%장보연%요저
CD47%钙网织蛋白%乳腺肿瘤%免疫组织化学
CD47%鈣網織蛋白%乳腺腫瘤%免疫組織化學
CD47%개망직단백%유선종류%면역조직화학
CD47%Calreticulin%Breast neoplasms%Immunohistochemistry
目的:研究CD47和钙网织蛋白(CRT)在浸润性乳腺导管癌(IDCAs)组织中的表达及与临床病理特征、预后的关系。方法应用免疫组化方法(ICH)对128例IDCAs及其癌旁组织中CD47、CRT的表达进行检测,并分析其与临床病理指标以及预后的关系。结果癌组织中CD47的表达为81/128,显著低于癌旁组织表达的106/128(χ2=12.400,P<0.05);CRT的表达为50/128,高于癌旁组织的31/128(χ2=6.520, P<0.05),且各分子分型间表达差异有统计学意义(χ2=21.510,P<0.05),基底细胞样型和Her-(2+)/ER (-)型明显高表达。CD47的表达与肿瘤大小、分化程度、淋巴结转移相关(χ2=11.400、4.732、5.432,均P<0.05);而CRT的表达与肿瘤分化程度、肿瘤远处转移相关(χ2=10.810、6.770,均P<0.05)。在完成随访的98例患者中,5年生存率为68.37%。单因素生存分析显示CD47、CRT高表达组和低表达组在5年内生存率差异有统计学意义(χ2=5.231、13.069,均P<0.05),表达越高患者5年内生存率越低。结论 CD47、CRT与IDCAs预后差的指标相关,与5年内生存率显著相关,联合检测CD47和CRT对判断乳腺癌的预后有指导价值。
目的:研究CD47和鈣網織蛋白(CRT)在浸潤性乳腺導管癌(IDCAs)組織中的錶達及與臨床病理特徵、預後的關繫。方法應用免疫組化方法(ICH)對128例IDCAs及其癌徬組織中CD47、CRT的錶達進行檢測,併分析其與臨床病理指標以及預後的關繫。結果癌組織中CD47的錶達為81/128,顯著低于癌徬組織錶達的106/128(χ2=12.400,P<0.05);CRT的錶達為50/128,高于癌徬組織的31/128(χ2=6.520, P<0.05),且各分子分型間錶達差異有統計學意義(χ2=21.510,P<0.05),基底細胞樣型和Her-(2+)/ER (-)型明顯高錶達。CD47的錶達與腫瘤大小、分化程度、淋巴結轉移相關(χ2=11.400、4.732、5.432,均P<0.05);而CRT的錶達與腫瘤分化程度、腫瘤遠處轉移相關(χ2=10.810、6.770,均P<0.05)。在完成隨訪的98例患者中,5年生存率為68.37%。單因素生存分析顯示CD47、CRT高錶達組和低錶達組在5年內生存率差異有統計學意義(χ2=5.231、13.069,均P<0.05),錶達越高患者5年內生存率越低。結論 CD47、CRT與IDCAs預後差的指標相關,與5年內生存率顯著相關,聯閤檢測CD47和CRT對判斷乳腺癌的預後有指導價值。
목적:연구CD47화개망직단백(CRT)재침윤성유선도관암(IDCAs)조직중적표체급여림상병리특정、예후적관계。방법응용면역조화방법(ICH)대128례IDCAs급기암방조직중CD47、CRT적표체진행검측,병분석기여림상병리지표이급예후적관계。결과암조직중CD47적표체위81/128,현저저우암방조직표체적106/128(χ2=12.400,P<0.05);CRT적표체위50/128,고우암방조직적31/128(χ2=6.520, P<0.05),차각분자분형간표체차이유통계학의의(χ2=21.510,P<0.05),기저세포양형화Her-(2+)/ER (-)형명현고표체。CD47적표체여종류대소、분화정도、림파결전이상관(χ2=11.400、4.732、5.432,균P<0.05);이CRT적표체여종류분화정도、종류원처전이상관(χ2=10.810、6.770,균P<0.05)。재완성수방적98례환자중,5년생존솔위68.37%。단인소생존분석현시CD47、CRT고표체조화저표체조재5년내생존솔차이유통계학의의(χ2=5.231、13.069,균P<0.05),표체월고환자5년내생존솔월저。결론 CD47、CRT여IDCAs예후차적지표상관,여5년내생존솔현저상관,연합검측CD47화CRT대판단유선암적예후유지도개치。
Objective To evaluate the expression of CD47 and calreticulin and their relationships with clini-copathologic features,prognosis in infiltrating ductal breast carcinomas.Methods The expression of CD47 and calret-iculin was evaluated in 128 cases with infiltrating ductal breast carcinomas by means of immunohistochemistry,and the relationship between CD47 and other clinicopathologic factors as well as prognosis were analyzed.Results The expression level of CD47 in cancer nest was 81/128,which was lower than 106/128 in its adjacent normal epithelium (χ2 =12.400,P<0.05),but calreticulin expression was 50/128 and was higher in cancer nest(χ2 =21.510,P<0.05 ).In addition,the expression level of calreticulin had certain difference in different molecular subtype (χ2 =21.510,P<0.05),and an increased expression in Basal-like and Her-(2 +)/ER(-)subtypes.The expression level of CD47 was associated with tumor sizes,histological tumor grade and lymph node involvement(χ2 =11.400, 4.732,5.432,all P<0.05),and the expression level of calreticulin was associated with histological tumor grade and distant metastasis(χ2 =10.810,6.770,all P<0.05).The 5 -year survival rate of patients performed following-up was 68.37%.Univariate analysis indicated the survival rate in 5 years of high level CD47,calreticulin expression was higher than that of low level CD47,calreticulin expression(χ2 =5.231,13.069,all P<0.05).Conclusion The expression of CD47,calreticulin is associated with index of dysprognosis and survival rate in 5 years,so combined CD47 and calreticulin detect may be of prognostic value in patients with breast caner.